StemCell Therapy

Retinitis pigmentosa (RP) is the name given to a group of hereditary eye conditions called retinal dystrophy.

Retina dystrophy, such as RP, affects the retina behind the eye, and over time the retina becomes non-functional.

This means that RP causes gradual but permanent changes that reduce vision.

How much vision you lose, how quickly this happens, and the age at which it begins depends on the type of RP you have.

Changes in your eyesight occur over the years, not months, and some people lose their eyesight more than others.

What are the symptoms of RP?

With retinal dystrophy like RP, the rod and pyramidal cells of the eye gradually fail.

Depending on the type of RP you are using, you may notice the first symptoms between the ages of 10 and 30 after infancy.

Some people are asymptomatic until later in life.

With RP, the first symptom you notice is that you dont look like a person without vision in dimly lit places, such as at dusk or at night. This is often referred to as night blindness.

People without vision can fully adapt to dim light in 15-30 minutes, but when using RP it takes much longer or does not occur at all.

You may start to have trouble seeing things in the peripheral vision. You may miss things on either side of you, and you may trip over or bump into what you might have seen in the past.

As the RP progresses, peripheral vision is gradually lost, leaving a narrow central vision. This is often referred to as tunnel vision. You may still have a central vision until you are in your 50s, 60s, or older.

However, advanced RP often affects central vision, which can make it difficult to read and recognize the face.

RP is a progressive state. In other words, eyesight keeps getting worse year by year.

In many cases, changes in vision can occur suddenly in a short period of time. That way, you may get some vision for quite some time. However, the vision may change further in the future.

This may mean that you need to continue to re-adapt to lower levels of vision. The type of RP you are using can affect how quickly these changes occur.

What is the cause of RP?

RP is a hereditary disease caused by a defect in one of the genes involved in maintaining retinal health.

In RP, defective genes cause retinal cells to cease functioning and eventually die over time.

Researchers have identified many of the genes that cause RP and defects in it, but there are still other genes to discover.

Genetic testing

You can perform a genetic test to find out if there is a defective gene that causes RP.

This allows you to identify the defective gene that causes RP and to find out if your child has a defective gene that they may inherit.

A genetic test uses a blood test to look at a gene to see if it is defective.

Testing for RP and other hereditary retinal dystrophy is complex. Not all forms of these conditions are identified, as new defective genes are still being discovered.

Genetic counseling

Genetic counseling helps you understand the type of RP you have, how it may affect you in the future, and the risks of communicating that condition to the child you may have. Useful.

Genetic counseling is usually recommended when undergoing a genetic test. A genetic counselor will ask you more about your family tree and try to understand how RP is passed down to your family.

A genetic condition in your family can cause emotional concerns. Talking to a genetic counselor may help you and your family discuss your familys eye condition.

If you are thinking of starting a family, knowing the possibility of passing in any condition you have can help.

What tests are used to detect RP?

Optometrists (also known as opticians) can examine the retina to detect RP. If there are early signs of classic RP, there is a small but characteristic dark pigment mass around the retina.

Changes in peripheral vision can be detected by visual field testing. If your optometrist is worried after your eye exam, they can refer you to an ophthalmologist (hospital ophthalmologist) for further examination.

There are various tests that can diagnose RP. These tests also allow you to monitor how the RP changes over time.

Your ophthalmologist may be able to say that you have RP when you get the results of these tests, but the type of RP you have and the long term to your eyesight Tests that may not be known exactly if the effects are not genetic.

Some tests you may need to take include:

Source: Royal National Institute of Blind

Health: Blind (58 years old) partially recovered vision with pioneering gene therapy

Source link Health: Blind (58 years old) partially recovered vision with pioneering gene therapy

Read the original post:
Health: Blind (58 years old) partially recovered vision with pioneering gene therapy - Texasnewstoday.com

When kids struggle at school, parents and teachers try to identify the cause of the problem. They wonder whether the student can see or hear properly, or whether he or she has learning problems such as dyslexia. An ordinary eye test might show that a child can see perfectly well, but it may not tell the full story. Visual skills can be just as important as eyesight itself, and this point is often poorly understood or overlooked, says Gary Rodney, a behavioural optometrist and fellow of the International Academy of Orthokeratology and Myopia Control.

Being able to focus on an eye-test chart isnt enough. Its also important to be able to focus at various distances and change focus easily from one distance to another. Apart from being able to focus, eyes need to be able to track from one thing to the next. For example, when reading, the eyes must be able to scan from one word to the next without losing their place. At the same time, both eyes need to be able to work together as a team.

Over and above these basic visual skills, people need the ability to process spatial information, notice small differences between one thing and another, be able to coordinate what is done in relation to what is seen (eye-hand coordination), and be able to associate what is seen with what is heard.

Any issues with these visual skills will naturally result in problems with schoolwork. Up to 25 percent of children have visual difficulties of one kind or another, so having a thorough eye examination that includes testing of visual skills is a sensible step to take when children struggle at school.

Regular Optometrists and eye surgeons (Ophthalmologists) are trained to test how well one can see, but it takes further training to be able to comprehensively test all the visual skills needed to succeed at school.

Thats why many parents and educators eliminate issues with vision as a reason for children having difficulty with schoolwork too soon. After all, ordinary eye tests may show that a child has 20/20 vision, but without evaluation of the additional visual skills that will allow children to use their eyesight in learning, parents and teachers can mistake visual processing disorders for learning problems. As a result, the real issue is not addressed, and a child may be unable to fulfil his or her true potential.

Gary Rodney acknowledges that although full evaluation of vision and related visual skills can identify issues that are holding children back, other factors may contribute to difficulties with learning.

If a child is struggling at school, testing of visual and auditory skills are a good first step. Garys practice, Eyes in Design, located in Mosman, will also be able to refer parents to the relevant health practitioners if dyslexia or other learning problems are suspected but have not been diagnosed. Even when a formal diagnosis has occurred, addressing any visual skills difficulties will help children to deal better with the challenges they face.

Vision therapy is not a panacea, says Gary. However sometimes, its all thats needed to get kids on track. After all it has been shown that 80% of how we learn comes through the visual pathway. In other cases vision may not be the cause of the problem, or it may only be a contributing factor. Either way, Eyes in Designs vision therapists are ready to assist parents in finding the practitioners they need to help children with the learning challenges they face.

HEAR: Ultra106.5FM Interview with Gary Rodney Covid and Myopia: What you need to know!

For more information on vision therapy, or to book an appointment for a visual perception test online, visit the Smart Vision website:Optometrists Sydney: Optometry Services For Children and Adults | Smart Vision; for specific information about Myopia treatment and prevention visitMyopia Prevention: Solutions, Control And Treatment In Sydney; and for detailed information about Myopia Treatment visitOrthokeratology In Sydney: The Non Surgical Alternative.

To book an appointment for a thorough eye check-up,click hereor Call the Bondi clinic on (02) 9365 5047 or the Mosman clinic on (02) 9969 1600.

Syndicated byBaxton Media,The Market Influencers,Your Digital Marketing Agency.

See the original post here:
Eye Care Clinic Mosman Behavioural Optometrist Vision Therapy Visual Skills Test - PRWire

Global Bionic Eye Market is valued at approximately USD 183.5 million in 2019 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2020-2027. Bionic eye, also referred to as visual prosthesis, is an experimental visual device used to restore the visual function of the patient experiencing partial or complete blindness. Many devices and surgeries have been developed, typically modeled on the cochlear implant or bionic ear device, so as to heal the blindness of the individuals.

Bionic eye is usually considered as artificial eye which can deliver visual sensation to the brain and often helps the people to improve the vision abilities, which is resulting in the higher market growth across the globe. Furthermore, the rise in prevalence of ophthalmic diseases due to growing geriatric population, increasing funding by public and private organizations, and intensive research and development (R&D) focused on product innovation are the few factors responsible for the impressive CAGR of the market during the forecast period. According to the World Health Organization, nearly 2.2 billion people were affected with vision impairment or blindness in October 2019, of which at least 1 billion people had preventable or unaddressed conditions around the world. Similarly, as per the International Agency for the Prevention of Blindness, in 2018, more than 21 million of Vietnamese required eye care services, Out of which over 3 million Vietnamese students are having eyesight problems. Thus, surge in vision-related complications may promote the adoption of the therapeutic or corrective devices, which has led to a boost in the demand for bionic eye all over the world. However, the high cost of bionic eye and the high research and development cost are the prime factors limiting the market growth over the forecast period of 2020-2027.

Request for a FREE sample of this market research report@ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1695

The regional analysis of the global Bionic Eye market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising awareness concerning vision-related problem, intensive research activities, and the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence eye-related or ophthalmic disorder such as myopia and presbyopia coupled with growing geriatric population across developing countries, such as China and India, would create lucrative growth prospects for the Bionic Eye market across the Asia-Pacific region.

Major market player included in this report are:Second Sight Medical Products LLCNidek Co. Ltd.Nano Retina Ltd.MetaModal LLCBiomedical TechnologiesBionic Vision TechnologiesNeoStrataMonash Vision GroupPixium Vision

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:External EyeImplanted Eye

By Technology:ElectronicMechanical

By End-Use:HospitalsOphthalmic ClinicsOthers

By Region:North AmericaU.S.CanadaEuropeUKGermanyFranceSpainItalyROE

Asia PacificChinaIndiaJapanAustraliaSouth KoreaRoAPACLatin AmericaBrazilMexicoRest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018Base year 2019Forecast period 2020 to 2027

Send a request to Report Ocean to understand the structure of the complete report @https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1695

Target Audience of the Global Bionic Eye Market in Market Study:

Key Consulting Companies & AdvisorsLarge, medium-sized, and small enterprisesVenture capitalistsValue-Added Resellers (VARs)Third-party knowledge providersInvestment bankersInvestors

Read more:
Bionic Eye Market Size Prognosticated to Perceive a Thriving Growth by 2027 interpreted by a new report The Courier - The Courier

Published:Monday,May 24, 202123:28

After 40 years of blindness from a neurodegenerative disease, a man has partially regained his sight thanks to visual therapy. The treatment consists of Injection of an adenovirus into the eye Which carries a light-sensitive protein from moss and special glasses. This is the first case of partial healing of vision in a blind patient after visual genetics therapy, a technique developed at the beginning of the century that It is based on processing microbial proteins that are sensitive to light And cells across the light.

The study, published in Nature Medicine, was signed by scientists from the Sorbonne (France), the University of Pittsburgh (USA) and the University of Basel (Switzerland). The patient is a 58-year-old man who lives in Paris He was diagnosed four decades ago with retinitis pigmentosa, a progressive neurodegenerative disease that destroys light-sensitive cells in the retina and causes complete blindness. After treatment and after a period of adaptation and learning to use technology, The patient was able to locate, recognize, and count the various objects Using the treated eye while wearing glasses.

The man could not visually detect any objects before the injection or without glasses after the injection. Hope its a breakthroughFirst author Jos Alan Sahel of the University of Pittsburgh and the Sorbonne said that the eye is an extremely complex system that allows our vision to adapt to different levels of light. Very fragile, so when the vision disappears, he noted, there are few treatments, except for the use of prostheses or the reactivation of the remaining cells in the retina.

Retinitis pigmentosa is caused by mutations in more than 71 different genes, leading to the development of gene therapies that replace a small number of proteins to repair broken cellular machinery It is tricky and not very effective. So the team approached the problem from a different angle: Instead of fixing mutated genes one by one in cells that respond to light by activating retinal neurons, they decided to directly activate neurons, which they used. Opto-Genetic Tools.

The team injected one of the patients eyes A vector associated with an adenovirus that carries genetic information, Which encodes a photosensitive protein called ChrimsonR channelrhodopsin, which is found in natures shiny algae. This protein responds to light by changing its shape and allowing ions to flow in and out of cells, which activates them, and in the case of neurons experimentally designed to express the rhodopsin channel, causes them to be released and the signal to be transmitted through the nerve endings to the brain.

Scientists have devised a way to convert light bouncing off objects in our environment into a single wavelength of the amber spectrum

Researchers chose ChrimsonR due to its preference for activation by amber light, which is safer and causes less pupillary constriction than the blue spectrum. The target was retinal ganglion cellsThat is, neurons that capture signals from the sticks and rods and transmit them through the optic nerve to the brain, where this information is processed to be perceived as a visual image. Scientists to activate ganglion cells in this way They have devised a way to divert the light that bounces off objects in our environment With a single wavelength of the amber spectrum, they used special glasses equipped with a special camera.

The University of Pittsburgh said in a statement that this camera captures images from the visual world and converts them into light pulses that are projected onto the retina in real time to activate the modified cells during visual tasks. It takes time to adjust to the use of glasses, Sahl recalls. At first, the patient didnt find them very helpful, however After a few months, he began to see the white lines of the pedestrian crossing After several training sessions, he was able to learn about other things, big and small.

Originally posted here:
Scientists create a blind man for 40 years who partially regains his eyesight - thedailyguardian.net

Tesla announced this week that a key component in its self-driving technology platform is about to move from radar sensors to optical sensors. Tesla calls its technology "Pure Vision." This is not exactly a shift to some higher level of technical know-how. Subaru has been using optical sensors to provide driver-assist features for much of the past decade. Armchair engineers and Tesla fans are now debating the shift in technology from one type of transducer to another. All I want to know is will the new sensor array stop Teslas cars from crashing into police cars, firetrucks, semi-trailers, highway barriers, and other static objects.

What Do Driver Assist Sensors Do?Stopping cars from crashing is one of the objectives behind the move to driver-assist technology. Tesla calls its two packages Autopilot and Full Self-Driving. Those names were chosen specifically to give you the impression that these vehicles can drive themselves. This begs the question; If they can drive themselves, even in certain circumstances, they must be able to see and avoid parked firetrucks with flashing lights, reflective tape and flares deployed ahead of the vehicle, right? Nope. Or they must at least be able to stop instead of crashing straight into the side of the largest vehicles on the road, tractor-trailers, right? Nope.

Does Teslas New Technology Prevent Crashes?For five years, Tesla vehicles equipped with the old technology have been regularly driving themselves straight into huge things anyone with eyes could see. Maybe this shift away from radar and toward optics is Teslas attempt to stop these seemingly preventable crashes from happening. Or maybe not. If not, then will Tesla vehicles continue to drive at high speed into emergency vehicles assisting motorists during highway emergencies? Although Tesla has not said if this technology shift will prevent the high-profile seemingly preventable crashes showering it with bad press, Teslarati reports that Elon Musk did say it would stop the phantom-braking reported by many Tesla drivers.

Are Tesla Crashes Common?If you are not up to speed on the types of crashes we are referring to, simply type Tesla hits firetruck into your browser. In under one second, your computer will provide you with over 7 million options to read more about this topic. The first story that comes up when I do the search is one from Car and Driver titled, NHTSA Investigating Indiana Crash Where Tesla Model 3 Hit Fire Truck.

Alternatively, you can type, Tesla hits semi. This search will show you about three million results. The top story on my browser is one from the Tesla-advocacy publication Inside EVs titled UPDATE: Tesla Crashes Into Another Semi: Federal Investigation Underway.

Whether or not an occupant (the word "driver" is so old school) enables a system inside of her Tesla or not is irrelevant. Driver-assist safety systems dont need to be turned on to work. All modern cars have advanced automatic emergency braking designed specifically to stop you from accidentally driving straight into firetrucks and semi-tractors. Yet, Teslas system seems to ignore these hazards on a regular basis and allow the vehicle to drive into them. How does that square with a company that advertises a product called Full Self Driving? Perhaps it doesnt, and perhaps the new sensors are an attempt to stop the seemingly preventable crashes.

How Can I Learn More About Unusual Tesla Crashes?The below list of prior stories may help provide background on the subject of Tesla vehicle crashes that were not prevented by the radar-based technology that Tesla has employed up to now.

Tell us in the comments below if you think Teslas technology shift will help stop future crashes of its vehicles into large, easy-to-see objects.

Image note: The top of page image is an old picture of Subaru's now mature Eyesight camera-based driver-assist system.

Past Stories Related To This Topic:May 2021: Five Years After First Tesla Tragedy Seemingly Preventable Crashes Still OccurApril 2021: Video of Tesla Model Y On Autopilot With No Driver Demonstrates Need For Government InterventionMarch 2021: Another Tesla Hits Another Semi From the Side - This Time It Looks Like a Model YAugust 2020: Tesla Operated By Full Self Crashing System Hits Two Parked First Responder Vehicles - AgainJuly 2020 - Police: Tesla On Autopilot Hits Not One, But TWO Parked First Responder VehiclesJanuary 2020: Second Crash In One Month Of A Tesla Into A Parked Firetruck Results In FatalityDecember 2019: Tesla Model 3 On Autopilot Hits Yet Another Police Vehicle - Why Won't They Stop?August 2018: Third Tesla Crashes Into Back of Firetruck - That's Four Crashes Into Emergency Vehicles This YearMay 2018: Another Tesla On Autopilot Hits Another Emergency Vehicle - You Can't Make This Stuff UpJanuary 2018: Tesla Police Blotter News - Tesla Driver Hits Parked Firetruck - Blames AutopilotJuly 2016: Understanding the fatal Tesla accident on Autopilot and the NHTSA probe

John Goreham is a long-time New England Motor Press Association member and recovering engineer. John's interest in EVs goes back to 1990 when he designed the thermal control system for an EV battery as part of an academic team. After earning his mechanical engineering degree, John completed a marketing program at Northeastern University and worked with automotive component manufacturers, in the semiconductor industry, and in biotech. In addition to Torque News, John's work has appeared in print in dozens of American newspapers and he provides reviews to many vehicle shopping sites. You can follow John on TikTok @ToknCars, on Twitter, and view his credentials at Linkedin

Continue reading here:
Teslas New Optical Sensors - The End Of The Weird Crashes? - Torque News

a blind man He partially regained his eyesight for the first time with the help of light-sensitive proteins that researchers had extracted from algae.

Scientists have used a type of gene therapy called optogenetics to add light-sensitive proteins to the retina of the 58-year-old French to control cells at the back of his eye. Although he did not regain full vision as a result, a man who wore special glasses could once again recognize and count different objects.

The man, who was being treated in Paris, 40 years ago was diagnosed with retinitis pigmentosa, a condition that causes the light-sensitive cells to die on the surface of the retina. It is said that around two million people worldwide suffer from this disease.

In optogenetics, a relatively new approach in medicine, light-sensitive proteins are placed in individual neurons, allowing neuroscientists to influence the activity of these neurons with light. Researchers who published their findings in the professional journal Nature Medicine, Proteins used from algae and other microbes. Thus they can make every neuron sensitive to light.

At first, the patient wasnt able to see anything with the system, and that was very frustrating of course, explains co-author Jos-Alain Sahel of the University of Pittsburgh. And then he became spontaneously excited and reported that he was capable of white lines (From a pedestrian crossing, ed.) Across the street.

Christopher Petkoff, Professor of Neuropsychology at Newcastle University, Talks about a new teacher and indicates the importance of a follow-up study. This is a great development to restore vision using an innovative approach. The goal now is to find out how well this works in other patients with retinitis pigmentosa.

Read also:

Here is the original post:
The blind man regains partial vision after algae gene therapy - Dividend Wealth

As explained in the journal Nature, in a healthy retina, photoreceptors detect light and send electrical signals to the retinal ganglion cells (RGC), which then transmit the signal to the brain. The optogenetic therapy used completely bypasses damaged photoreceptor cells by using a virus to deliver light-sensitive bacterial proteins into the RGCs, allowing them to detect images directly bypassing the photoreceptors.

In the case study, the researchers injected the virus into the eye of a man with retinitis pigmentosa and waited four months for protein production by retinal ganglion cells to stabilize. The researchers then designed a prototype of glasses that capture visual information and optimize it for detection by bacterial proteins. The trial participant had to train with the glasses for several months before his brain adapted to interpret the points correctly. Finally, he was able to make out high-contrast images, including objects on a table and the white stripes on a crosswalk. When the researchers recorded your brain activity, they found that your visual cortex reacted to the image in the same way it would if you had normal eyesight. Of course, because the retina contains around a hundred times more photoreceptors than RGCs, the resolution of the images detected by RGCs will never be as good as natural vision.

Although the trial has been completed in just one person, six others have been injected with the same light-sensitive proteins, but the pandemic has delayed their training and the researchers hope to have results soon. We will have to wait to find out if these results are replicable, since the results cannot be generalized since it is a single person. This is a high-quality study, which is carried out and controlled with great care, James Bainbridge, professor of retinal studies at Global University in London, told the Science Media Center, who was not involved in the study. . The problem is that the findings are based on laboratory tests performed on a single person, so more work will be needed to find out if this technology is really useful. The press release describes improved recognition of the objects, but there is no evidence in the study results, He clarifies.

Follow this link:
A blind man partially recovers his vision thanks to optogenetic therapy Explica .co - Explica

The latest analysis released by HTF MI on Global Eyesight Test Equipment Market Outlook 2020 Survey results sheds light on how investment and competitive landscape is impacted due to significant changes in the Eyesight Test Equipment Industry. The research coverage includes analysis on companies such as Bhavana MDC, Heidelberg Engineering GmbH, EyeNetra, Essilor International, Johnson & Johnson Vision Care.Inc., Alcon, Inc., Shenzhen Certainn Technology, Heine, Abbott Medical Optics.Inc., Nidek Co., Ltd., Seiko Optical Products Co., Ltd., Carl Zeiss AG & Hoya Corporation etc. It is expected that the healthcare and life sciences industry will likely continue to be an attractive target market showing noteworthy sign to Eyesight Test Equipment for the foreseeable future.

Get one step closer to market leaders and emerging players of Eyesight Test Equipment Market.Get Sample Pages for Quick Illustration @:https://www.htfmarketreport.com/sample-report/3228050-global-eyesight-test-equipment-market-17

Eyesight Test Equipment Companies are expanding their roles to deliver value beyond the services or offerings by helping clinics and hospitals authority report on quality, offering services that engage patients in real time, improving safety, regulatory compliance and physician performance.

According to Sources, national healthcare spending is projected to grow at an average of 5.5% annually

Lot of Eyesight Test Equipment Companies expect that health cares evolution will have far-reaching impacts as upcoming business models emerge that blur boundaries and drive cross-sector and cross-industry convergence. With this edition, HTF MI have come up with a scope that actually delivers answer to current and future scenario.

Make an Enquiry for Global Eyesight Test Equipment Market Study @https://www.htfmarketreport.com/enquiry-before-buy/3228050-global-eyesight-test-equipment-market-17

The titled segments and sub-section of the Global Eyesight Test Equipment market are illuminated below:

The Global Eyesight Test Equipment market has been divided into, application, type, technology and region/country.

On The Basis Of Type, Market is segmented by , Portable & Stationary, by Application/End Users it includes Children, Adults & The older

Geographically, the Eyesight Test Equipment Market Study provides Revenue Sizing as

North America: USA, Canada and MexicoEurope: Germany, France, the United Kingdom, Netherlands, Russia , Italy, Belgium, Denmark, Austria, Norway, Sweden, The Netherlands and Rest of EuropeAsia-Pacific: China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and OthersSouth America: Brazil, Argentina, Colombia, OthersMEA: Saudi Arabia, United Arab Emirates (UAE), Turkey, Israel, Egypt, Nigeria, South Africa & Rest of MEA

Additionally the connected stakeholders of Eyesight Test Equipment such as distributors, suppliers, health care providers, governments, other payers, patients, and other stakeholders were also considered in the survey to derive Eyesight Test Equipment market estimation and demand side analysis.- To better explore trend and current state to deliver closer view towards changing market dynamics of Eyesight Test Equipment Market.

Buy Latest Edition of Eyesight Test Equipment Market Research @https://www.htfmarketreport.com/buy-now?format=1&report=3228050

Some Frequency Asked Questions

1) How can we add or get new players profile as per our need?

Yes, we can add or profile new company as per client need in the report. Final confirmation to be provided by research team depending upon the difficulty of survey. The Standard version of the report currently profiles players such as Bhavana MDC, Heidelberg Engineering GmbH, EyeNetra, Essilor International, Johnson & Johnson Vision Care.Inc., Alcon, Inc., Shenzhen Certainn Technology, Heine, Abbott Medical Optics.Inc., Nidek Co., Ltd., Seiko Optical Products Co., Ltd., Carl Zeiss AG & Hoya Corporation.

** Data availability will be confirmed by research in case of privately held company. Up to 3 players can be added at no added cost.

2) Can we have different set of Segmentation added or further granularity in existing segmentation is possible?Yes, inclusion of additional segmentation in Eyesight Test Equipment Market Study is possible subject to data availability and difficulty of survey. Also, granularity can be checked contacting sales team as customization are subject to final approval and feasibility check by research team.

3) What years are considered in Global Eyesight Test Equipment Market study; When it was last released?Historical year 2016-2020Base year 2020Forecast period** 2021 to 2026 [** forecast year can be customized]Version of Study: 2021 Published

browse complete report and table of contents @https://www.htfmarketreport.com/reports/3228050-global-eyesight-test-equipment-market-17

Thanks for showing interest in Eyesight Test Equipment Market publication; you can also get Individual Chapter or Regional or Country wise report USA, GCC, Southeast Asia, North America, Europe, APAC or LATAM.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218sales@htfmarketreport.com

Connect with us atLinkedIn|Facebook|Twitter

Go here to read the rest:
Eyesight Test Equipment Market Poised For Disruptive And Explosive Growth | Heine, Abbott Medical Optics, Nidek The Shotcaller - The Shotcaller

Global Bionic Eye Market: Introduction

According to Encyclopedia Britannica, Inc., bionic eye is an electrical prosthesis, which is surgically implanted into a human eye in order to allow for the transduction of light, i.e. the change of light from the environment into impulses the brain can process in people who have sustained severe damage to the retina. The bionic eye comprises an external camera and transmitter and an internal microchip. The camera is mounted on a pair of eyeglasses, where it serves to organize the visual stimuli of the environment before emitting high-frequency radio waves. In the U.S., the FDA has approved just one commercially available bionic eye system. The device, called the Argus II Retinal Prosthesis System, was developed by a California-based company Second Sight Medical Products. Different bionic eye models take aim at different target areas in the visual pathway. Bionic eye implants work inside the existing eye structure or in the brain. These are designed to achieve functional vision goals as opposed to physical, cosmetic ones.

Read Report Overview - https://www.transparencymarketresearch.com/bionic-eye-market.html

Key Drivers of Global Bionic Eye Market

Rise in Prevalence of Vision Loss

The global population has increased by 18.5% in 2002 over that in 1990. The population 50 years of age and older has increased by nearly 30%. Population increase is more prominent in developing countries. Health is the centerpiece of development and poverty alleviation continuing to eliminate avoidable blindness among the poorest of the poor is a moral imperative. According to The Lancet Global Health, a report estimated that in 2015, 36.0 million people were blind, 217 million had moderate and severe vision impairment, 188 million had mild vision impairment, and 667 million additional people had vision impairment from uncorrected presbyopia.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81541

Rise in Prevalence of Eye Diseases

According to the World Health Organization, globally, at least 2.2 billion people have a vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or has yet to be addressed. Tens of millions have a severe vision impairment and could benefit from rehabilitation, which they are not currently receiving. Aging population coupled with rise in sedentary lifestyle and unhealthy eating habits also contribute toward increase in number of people with eye conditions and vision impairment are likely to augment the global market.

Request for Analysis of COVID-19 Impact on Bionic Eye Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81541

North America to Account for Major Share of Global Bionic Eye Market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=81541

Key Players Operating in Global Bionic Eye Market

The global bionic eye market is highly consolidated owing to the presence of several key players.

Pre Book Bionic Eye Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=81541&ltype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: https://www.transparencymarketresearch.com/

Go here to see the original:
Bionic Eye Market: Rise in Prevalence of Eye Diseases is expected to drive the market - BioSpace

No one can dispute the value that our eyes hold in our lives. One of the most vital organs, a pair of good healthy eyes can not only help us safely and ably navigate the challenges in our day-to-day life but ensures a lifetime of attainment and self-realization. Conversely, a not-so-healthy pair of eyes can become such a debilitating handicap in our daily routine. While some minor as well as major eye diseases are fairly common and treatable, there are some which continue to pose a challenge to the ophthalmic community. Glaucoma is one of those eye conditions. If timely detection and treatment is not carried out, it can lead to an individual even losing his eyesight. In fact, glaucoma is one of the leading causes of irreversible blindness.

What is Glaucoma?

Glaucoma is a term used to depict a group of diseases which entail a progressive or irreversible damage to the optic nerve of the eye, which if untreated may lead to loss of sight. It is a result of the increased pressure inside the eye which usually happens because of the build-up of a fluid known as aqueous humor in the eye. As this fluid gets obstructed or blocked, the resultant increase in intraocular pressure can damage the optic nerve which in time can weaken the eyesight and eventually lead to complete loss of vision.

Mass screening doesnt help, opportunistic screening important

Unlike Cataract, which can be detected during mass screening of a given population, Glaucoma requires a patient to specifically visit an eye doctor. This visit could be for any eye condition when an opportunistic screening can reveal whether an individual has the dreaded eye condition or not. A comprehensive eye examination with a set of tests such as dilated eye exam (to widen pupils and view optic nerve), slit lamp exam (to view inside of eye), visual acuity test (to check for vision loss), tonometry (to evaluate eye pressure), gonioscopy (to check for eye drainage), pachymetry (to measure corneal thickness), optical coherence tomography (changes in optic nerve), optic nerve head examination (to examine loss of ganglion cells and their fibres), and visual field examination(to check for any peripheral vision loss) would need to be conducted in order to establish whether an individual has glaucoma or not.

Types of Glaucoma

Generally, there are three major types of glaucoma: primary open angle glaucoma (POAG), primary angle closure glaucoma (PACG) and Secondary glaucoma. POAG is the most common type and occurs when the drainage system gets choked and progresses imperceptibly over a long time. Then PACG, a more serious type, is the result of the iris being too close to the drainage canals in the cornea. In this, the eye pressure can rise suddenly due to complete blockage of the drainage angle and unless medically intervened immediately, the individual can lose his eyesight. In a variant called Normal Tension Glaucoma, the optic nerve is damaged without the eye pressure going beyond the average range and is caused by the abnormalities in the blood flow to the optic nerve, and structural weakness of the optic nerve tissue. NTG is not very common. Secondary glaucoma is caused by other diseases which may increase eye pressure leading to optic nerve damage. These include Pigmentary glaucoma, Pseudoexfoliativeglaucoma, traumatic glaucoma, neovascular glaucoma, Irido-Corneal Endothelial Syndrome and Congenital/Childhood glaucoma.

Signs and Symptoms of Glaucoma

Each type of glaucoma has its own signs and symptoms. For instance, POAG has no perceivable or visible symptoms in the early stages and in due course of time as the disease progresses, blind spots develop in the peripheral vision. Similarly, PACG exhibits no apparent symptoms as such and can lead to a sudden attack. Signs of an acute attack would include intense pain in the eye or forehead, foggy vision, redness in the eye, halos around eyes, nausea and vomiting. Again in NTG, blind spots emerge in the field of vision which is a symptom. The symptoms in Secondary glaucoma would depend on the additional disease which is responsible for glaucoma. For Childhood or Congenital glaucoma, a baby would show sensitivity to light and clouding of Cornea. Children are also likely to frequently rub their eyes.

Who are at risk?

Although it can afflict anyone, those with a family history, advanced age or with co-morbidities such as high blood pressure, heart disease or diabetes are more likely to be at risk of getting glaucoma. In addition, those who have been on corticosteroid medications for long, or have undergone certain eye surgeries are also more at risk. Importantly, those with normal eye pressure can also get glaucoma.

Treatment

Again, the line of treatment would depend on the symptoms, stage and type of glaucoma. Typically, there are three major forms of treatment: medication/eye drops, laser treatment and surgery. And often a combination of treatments is also followed. For instance, POAG is most often treated with a combination of eye drops and surgery. But PACG is treated with a laser procedure called iridotomy in which the doctor creates a small opening in your iris using a laser allowing fluid to flow through it, relieving eye pressure. Another laser procedure is called Trabeculoplasty which is used for POAG patients. However in some cases, operating room surgery is opted for. Trabeculectomy is an important surgery in which an opening in the white of the eye (sclera) is created whilea part of the trabecular meshwork is removed by the doctor. You must remember that surgery may require follow-up sessions and a repeat surgery may also not be impossible.For Infants and congenital glaucoma, surgery is the main treatment.

Therefore, glaucoma is aptly called the silent thief of sight. With 12 million people affected and nearly 1.2 million people being blind from the disease in India, mass-level awareness campaigns must be mounted throughout the country. Also, individuals of all age groups must subject themselves to a comprehensive eye examination periodically. Parents should be alert to their babys eye conditions.Because glaucoma simply doesnt give you a second chance.

Views expressed above are the author's own.

END OF ARTICLE

View original post here:
Glaucoma: A leading cause of irreversible blindness - The Times of India Blog

Dr. Marshall Walker will be the guest speaker for Stillwater Medical Foundations First Friday presentation March 5.

Walker is an optometrist whose topic will be Low Vision and Vision Rehabilitation. He is the only board certified low vision specialist in north central Oklahoma. First Friday is still a virtual event, so it will begin its Facebook live stream noon Friday.

1.Can you tell us a little of your background?

I earned his doctorate of optometry with honors from Pennsylvania College of Optometry. I trained at the prestigious Bascom Palmer Eye Institute in Miami, Florida and Feinbloom Low Vision Center in Philadelphia. Afterward, I completed a post-graduate residency in ocular disease and refractive surgery through Northeastern State University Oklahoma College of Optometry. I served as an assistant clinical professor at the Oklahoma College of Optometry and served at Indian Health Service Clinics throughout Northeastern Oklahoma before starting my practice at Stillwater Eyecare.

2. What are some highlights of your discussions?

Gain an understanding of the difference between low vision and blindness. Learn about the most common eye and brain conditions that can vision loss and how to avoid complications. Introduce assistive technologies to education attendees on ways to improve quality of life in individuals suffering vision impairment.

3. Can you give us an example of the kind of therapy involved in low-vision rehabilitation?

Vision rehabilitation is a team approach which includes a low vision specialist, occupational therapists, mental health professionals and social services coordinators. Different therapy recommendations depend on the needs of the individual patient. Specific rehabilitation therapies vary vastly and could be education of how to use a device to read text, or a training someone to navigate their environment with a white cane.

4. Whats a common misconception about eyesight?

Prevention is key. A common misconception about eyesight is a person will notice if they have a problem. There are many potentially blinding conditions that have no perceivable effects until the condition is advanced. This is why yearly comprehensive eye exams are so important.

5. Is there anything youd like us to know?

If someone has sudden vision change or loss, sudden eye pain or a red eye, they should call to be seen as soon as possible.

We are making critical coverage of the coronavirus available for free. Please consider subscribing so we can continue to bring you the latest news and information on this developing story.

See original here:
Q5: First Friday will feature discussion on low vision - Stillwater News Press

The Automotive Recognition System market study provides a comprehensive narrative of the global market landscape and lays out the essentials as well as the other business affecting factors for the client to better understand the market scope and potential. The Automotive Recognition System market report delivers information on various crucial business and market dynamics and anticipates the market growth in the forecast.

Request Sample Copy of the Report @https://www.reportsintellect.com/sample-request/1909489?ata

NOTE: The Automotive Recognition System report has been formulated while considering the COVID-19 Pandemic and its impact on the market.

Key Stakeholders mentioned in this report: CogniVue, EyeSight Technologies, Intel, Qualcomm, Gestsure Technologies, Microsoft

This research study will help you in strengthening the position of your business and organization in the global Automotive Recognition System market landscape. The report will help you to draft strategies that will sustain your business in the long term and give you credible information to implement these strategies in the most effective way possible.

Based on Type Coverage:

Hand/Leg/Finger Print RecognitionFace RecognitionVision/Eye Recognition

Based on Application Coverage:

MultimediaLightingsOthers

Based on Regions and included:

North America(the United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Get a Discount on this report @https://www.reportsintellect.com/discount-request/1909489?ata

Scope:

The Automotive Recognition System market comes up with detailed information related to critical aspects which are essential for a good growth strategy in the market landscape. The market study also profiles the vital players and details their business models.

Highlights of Automotive Recognition System Market Report:

About Us:

Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in todays competitive world.

Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you.So whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Contact Us:

[emailprotected]Phone No: + 1-706-996-2486US Address:225 Peachtree Street NE,Suite 400,`Atlanta, GA 30303

Read more here:
Automotive Recognition System Market landscape are detailed in this report for your convenience by: CogniVue, EyeSight Technologies, Intel, Qualcomm,...

Some of the most recognizable traditional sports players in the world wear Oakley. Now, Oakley can add Call of Duty League All-Star Seth Scump Abner to its roster to go alongside other Oakley athletes such as Patrick Mahomes, JuJu Smith-Schuster, Erika Hara, and others. Abner, who currently plays for OpTic Chicago, is now the first-ever esports athlete to sign with the iconic sunglass maker. Abner will be relying on Oakleys first eye-wear solution developed specifically for gaming Prizm Gaming Lens Technology.

Why Oakley? The name speaks for itself. When you hear the word Oakley, you think of a very prestigious brand in the glasses space, Abner told The Esports Observer. I watch a ton of sports. I see Oakley all over the place. My favorite sport to watch is baseball and you see those players wearing them every day. Oakley is just an amazing brand, a very cool, and a very hip brand as well. I think Oakley just kinda speaks for itself.

Oakley, with roots already laid deep inside the traditional sports space, sees esports as another competitive space where players share in the pursuit of progression, giving it everything theyve got. Abner encapsulates that vision as he had had to overcome various vision problems in order to become the player he is today.

I cant see anything. Having glasses that help me see and are comfortable are the two most important things I need in a pair, Abner said. Playing at the highest level, I need to be able to see everything and react to everything perfectly with no discomfort. You dont want to have to worry about things inside of the game because of things outside of the game. These Oakleys are pretty much an attachment of me now.

Abner, who used to wear contacts which he said sometimes itch because of bad allergies, now says he wears glasses again. And the prescription lenses that come with a blue-blocking agent, have helped him tremendously.

I used to wear contacts quite a bit, but now I wear only glasses exclusively, Abner said. So again, its just really important and amazing that Ive found a pair that I really like helps with my eye strain. Its just as cool that the brand is Oakley.

Despite the ailments with allergies and eyesight, Abner has been able to dominate the Call of Duty esports scene. In fact, the two-time Major League Gaming (MLG) X Games gold medalist who was awarded the Best Console Player at the 2017 Esports Industry Awards is often referred to as The King.

Ive been wearing their product for probably two months now, Abner said. The prisms fit perfectly under my Turtle Beachs [headset]. With the Oakleys and the Turtle Beachs, I have no strain on the top of my ears, which after eight hours, you can imagine how much that would hurt. I havent had any issues with these so far and theyre just really comfortable and easy to wear while Im gaming.

However, it wasnt just Abners skill in playing Call of Duty that saw Oakley reach out to him for this partnership, but also his philanthropic endeavors. Abner has grown into a global ambassador for esports by interacting with his fans and followers through various forms of content creation. He has also participated in charity streams and recently took part in a philanthropic campaign to honor those battling COVID-19.

Read more from the original source:
Seth 'Scump' Abner Signed by Oakley as its First Professional Esports Athlete - The Esports Observer

Mrs Beryl Close, from Tonypandy. Image:Freshwater.

Submitted by Freshwater on behalf of Specsavers

A Rhondda man was so concerned about his mother's eyesight and that it was affecting her mental health, that he arranged for an optician home visit during lockdown.

Beryl Close, 75, from Tonypandy in the Rhondda Valley, struggled with her mobility and when her eyesight started worsen during the lockdown. So much so that it began to have a big impact on her life.

Her son, Mike, got in touch with Specsavers, as he was concerned about his mums vision. She couldnt read or see the TV and he was worried that it was affecting her mental health.

During his visit to see Mrs Close, optometrist and director of home visits in Cardiff and the Vale of Glamorgan for Specsavers, Jason Scaife found that she had bad cataracts in both eyes and needed surgery. Cataract removal surgery is a quick procedure, which takes between 15 to 45 minutes, and leaves patients with much brighter and clearer vision.

Having had her surgery at Nuffield Health Hospital in Cardiff Bay to remove the cataracts, Mrs Close has now made a full recovery.

Mr Scaife said: "Her whole demeanour was different after the operation. It became evidently clear that it was her sight problems that were causing her anxiety. She was back to her usual self after the procedure, which was heart-warming to see.

"Beryls story is yet another example of why primary health services cannot stall because of Covid-19. We completely understand why people may be anxious to seek treatment and medical advice while Covid-19 remains prevalent in our communities, which is why our staff both those working remotely as well as colleagues in Specsavers stores have worked hard to ensure we are Covid-secure at all times."

Specsavers staff use personal protective equipment (PPE) while visiting someones home and thoroughly sanitise all equipment and glasses frames between appointments.

Specsavers stores and home visits service in Wales currently remain open for all eye and hearing needs. Specsavers will adhere to each countrys industry guidance if and when changes to local rules are made.To find out more information, request an appointment or browse the online store, visit http://www.specsavers.co.uk/stores.

Read the original post:
Optician's home visit helped save Rhondda woman's deteriorating eyesight - In Your Area

NESS ZIONA, Israel--(BUSINESS WIRE)--Foresight Autonomous Holdings Ltd., an innovator in automotive vision systems (Nasdaq and TASE: FRSX), today reported financial results for the fourth quarter and full year 2020. Foresight ended the fourth quarter of 2020 with $43.9 million in cash and short-term deposits.

Foresight reported a GAAP operating loss of $12.84 million for the full year 2020 which is an approximately 15% less than the GAAP operating loss of $15.03 million reported for the full year 2019. Foresight reported a GAAP net loss of $3.96 million and $15.32 million for the fourth quarter 2020 and the full year, respectively, and a non-GAAP net loss of $3.71 million for the fourth quarter and $14.16 million for the full year 2020.

We achieved important key milestones during the fourth quarter of 2020 and maintained solid progress throughout the year in spite of the COVID-19 pandemic, said Haim Siboni, Foresights CEO. We are entering 2021 with a strong balance sheet, following successful capital raises including $26 million raised in our registered direct offering announced on December 28, 2020. We will continue to build on our innovative product portfolio, which has been validated through key prototype orders and partnerships in Europe, Asia and North America.

The successful year also extends to our subsidiary, Eye-Net Mobile, and our affiliate, Rail Vision. Both companies achieved major business milestones during the fourth quarter of 2020, as Rail Vision received a second investment of $10 million from a leading Tier One European-based group, Knorr-Bremse, in October 2020, and Eye-Net Mobile signed a distribution agreement with Cornes Technologies, a leading Japanese trading house. We believe that Rail Vision and Eye-Net Mobile are poised for further growth in 2021, concluded Mr. Siboni.

Fourth Quarter 2020 Financial Results

Full Year 2020 Financial Results

Full year endedDecember 31,

Three months endedDecember 31,

(thousands of U.S. dollars)

2020

2019

2020

2019

GAAP Results

Net loss

$(15,324)

$(15,439)

$(3,964)

$(4,370)

Non-GAAP Results

Net loss

$(14,162)

$(13,476)

$(3,712)

$(4,018)

Balance Sheet Highlights

Fourth Quarter Corporate Highlights:

Use of Non-GAAP Financial Results

In addition to disclosing financial results calculated in accordance with United States generally accepted accounting principles (GAAP), the company's earnings release contains non-GAAP financial measures of net loss for the period that excludes the effect of share-based compensation expenses, the revaluation of other investments and revaluation of derivative warrant liability, and non-GAAP financial measures of shareholders equity that excludes the effect of derivative warrant liability and the revaluation of other investments. The companys management believes the non-GAAP financial information provided in this release is useful to investors understanding and assessment of the company's ongoing operations. Management also uses both GAAP and non-GAAP information in evaluating and operating business internally and as such deemed it important to provide all this information to investors. The non-GAAP financial measures disclosed by the company should not be considered in isolation or as a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. Reconciliations between GAAP measures and non-GAAP measures are provided later in this press release.

About Foresight

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the companys wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both in-line-of-sight vision systems and beyond-line-of-sight accident-prevention solutions.

Foresights vision solutions include modules of automatic calibration, sensor fusion and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobiles cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit http://www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as expects, anticipates, intends, plans, believes, seeks, "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses its belief that it is entering 2021 with a strong balance sheet, that it will continue to build on its innovative product portfolio, which it believes has been validated through key prototype orders and partnerships in Europe, Asia and North America, that it believes that Rail Vision and Eye-Net Mobile are poised for further growth in 2021, Rail Visions expected revenue from Knorr-Bremse, and that Foresight will work with students from the University of Michigan to further develop its automotive vision system designed for Advanced Driver Assistance Systems and autonomous vehicles. Because such statements deal with future events and are based on Foresights current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading Risk Factors in Foresights annual report on Form 20-F filed with the Securities and Exchange Commission (SEC) on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

FORESIGHT AUTONOMOUS HOLDINGS LTD.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

As ofDecember31, 2020(Unaudited)

As ofDecember31, 2019

ASSETS

Current assets:

Cash and cash equivalents

$

38,772

$

4,827

Short term deposits

Link:
Foresight Announces Fourth Quarter and Full Year 2020 Financial Results - Business Wire

Richards EyeSight Max Pills Reviews Can it protect your eyesight effectively? User exposed the truth! Must read before buy.

Official Website: Click Here

What is EyeSight Max?

EyeSight Max is one of the biggest dietary supplements that have been formulated to help thousands of people to help fix their eyesight.

EyeSight Max is for all those people who have lost their vision and are willing to get it back in the most natural and effective manner.

If you are someone who hates the idea of surgeries or living your entire life with the help of spectacles, then, EyeSight Max product is the best thing that can ever happen to you.

The formula not only helps you cure eye problems but it will make sure that you never suffer from them once again.

The formula has been made with the best herbs and ingredients that have been carefully chosen to help you have an effective living.

Eye Sight Max has undergone several tests and researches before it got launched to ensure safety.

Each bottle of Eye Sight Max has been made right here in the USA in an FDA registered and Goods Manufacturing Practices certified facility.

EyeSight Max is made under strict, sterile, and precise standards that ensure the highest quality.

Thousands of people have used the solution and have received the best results in a very short period of time which is quite impressive in comparison with other products.

Which are the ingredients used to formulate the EyeSight Max formula?

As I mentioned above, the formula has been made using the best herbs and ingredients so that it works effectively for all.

EyeSight Max solution is made with 3 potent nutrients that are sourced from the highest and cleanest places on the earth.

These ingredients have been combined together in their best qualities and are added in proper proportions and quantities which ensure the safety and effectiveness of each and every ingredient.

The best part about these superfoods is that they have been tested and proven scientifically and clinically to be highly potent.

Let us know these superfoods below:

Visit The Official Website Here to Find a Discounted Price!

How does EyeSight Max work so well?

EyeSight Max is made effectively in order to help you have an enhanced vision. The formula is simply based on an ancient formula by the Navajo tribe.

Thus, the solution is backed by all scientifically proven all-natural ingredients that have the ability to help detoxify your body.

The food we consume is highly filled with toxicants that are extremely harmful to our bodies.

Thus, EyeSight Max is made with a natural antioxidant that will help your body flush out the PM 2.5 chemicals that can cause fatal disease to take place and will also cause the ocular system dysfunctional.

Thus, the first step the ingredients will do is to get absorbed immediately and then reverse the damage caused by these toxins.

Through this, you will have an enhanced vision for life

Click Here to Get EyeSight Max For an Exclusive Low Price Now

What are the pros and cons of consuming EyeSight Max every day?

EyeSight Max has both pros and cons.

But the pros will leave you happy to the core! Because the formula will improve your overall life and will protect your overall health while providing some of the best health benefits daily such as:

These were the amazing pros, now, let us take a look at the cons of the Eye Sight Max formula:

How much of EyeSight Max is to be taken daily?

As I already mentioned above, it is highly crucial to consume the formula every day without fail.

Regular consumption helps you have fast results that are accurate. So, you are supposed to consume the formula daily.

All you have to do is consume 2 pills of EyeSight Max solution every day after lunch and dinner with a big glass of water.

Once you continue consuming the formula every day, you will be able to get the results in just a few days.

Most people have been able to experience the results within just 3 weeks only. Although the results may vary on the basis of time.

This happens because our bodies have different capacities and ability to adapt to certain things that can cause a bit of delay in results.

But it will be worth the wait!

Click to Order From The Official Website & Get The Lowest Price Online

How much does the EyeSight Max solution cost?

EyeSight Max has been made available at the cheapest and highly discounted prices. You can choose from the offers below:

Does the EyeSight Max formula have a refund policy?

It is completely fine to be confused. It is okay! After all, you have earned all that money from working really hard daily.

I am sure you must be thinking about what happens when you are not happy with the product!

Thus, to ensure that every consumer of Eye Sight Max is happy and satisfied, the manufactures of the Eye Sight Max formula have come up with an amazing refund policy!

This refund policy is a full 60 days of 100% money-back guarantee.

So, you can now try and test this solution for one or two months and see how it works for you.

If the results make you unhappy and if you are not completely satisfied with it, you can simply contact the makers and ask them for a complete refund without any hesitation.

Click to Order EyeSight Max For The Lowest Price Here!

Overall review of the Eye Sight Max solution:

Unlike other formulas and solutions, EyeSight Max product is one of the best formulas people can refer to!

EyeSight Max has been formed in the best manner that helps you have an enhanced vision in the easiest and most natural way possible.

Unlike other supplements that are made with chemicals, toxicants, preservatives, additives, fillers, and harmful stimulants, the entire formula has been made with only pure ingredients that are sourced from the best places.

They are each pure and safe for regular consumption! EyeSight Max is free from all kinds of side-effects and risks.

With EyeSight Max, you will not only have enhanced vision but you will also receive thousands of health benefits.

You will get the best results in just a few days.

Also, I am sure you must have thought that it would cost you a fortune but it does not! It is super affordable and is worth it.

So, what are you waiting for? You must hurry up because the offers will not last that long.

Click to Get Your Hands On EyeSight Max Now!

Originally posted here:
EyeSight Max Supplement Reviews [UPDATED] - The Best Eye Supplement? Effective Ingredients? - L.A. Weekly

BALTIMORE, Feb. 11, 2021 /PRNewswire/ --Today,Versant Health, released the results of the 2nd annual Vision Wellness Study, which found Americans, in particular young adults under 40, are showing a new interest in the use of virtual technology and telemedicine for eye care.

The Vision Wellness Study surveyed consumers and health plan executives on their perceptions of eye care in a pandemic environment, including the value they place on eye care services and their beliefs about the impact of eye care on overall health.

Almost three quarters (74%) of respondents under 40 say having access to technology and tools for virtual visits would make them more likely to schedule a routine eye exam, compared to 67% of all respondents. More than one third (38%) of people under 40 say that being able to communicate remotely with eye doctors would have a high impact on seeing an eye doctor more often, compared to 34% of people ages 40-59 and just 15% of people ages 60 and over. Health plan executives also see the value of telemedicine76% of those surveyed believe members' use of alternatives to face-to-face contact with eye doctors will increase substantially or somewhat as a result of the pandemic.

"With COVID-19 as the backdrop, patients are showing an increased desire for convenient and easily-accessible eye care using remote technology," said Dr. Mark Ruchman, Chief Medical Officer at Versant Health. "As we look to the future of eye care, ocular telemedicine will play an important role in improving access to care, as patients are provided more ways to address their eye health on their own terms."

Perceptions of Eye Care Value vs. Costs

Overall, Americans are increasingly recognizing the importance of eye care, with 81% of respondents receiving an eye exam in the past two years, compared to 77% who said the same in the inaugural study. For all respondents, including those who have not seen an eye doctor in the past two years, the ability to identify eye diseases and the ability to identify other serious health conditions, such as diabetes, ranked as the top two services that would make them more likely to schedule an eye doctor appointment, supporting the role of eye health as a window into overall health.

Of people who have not received an eye exam in the past two years, 37% say it's due to cost and affordability, pointing to a need to dispel misconceptions about the costs of eye care.

"Members are realizing that comprehensive eye exams can provide a clearer picture of their overall health," said Elizabeth Klunk, RN, BSN, CCM-R, Senior Vice President of Medical Management at Versant Health. "In fact, eye exams are one of the lowest cost and least invasive methods at looking at whole body health for early disease detection."

The Social Determinants of Eye Health

Despite the low cost of eye care, barriers to access persist, particularly for people in lower income households81% of all respondents say they have received an eye exam in the past two years, but only 68% of people in households with incomes under $35,000 say the same. When it comes to insurance, 69% of respondents say someone in their household has vision insurance, and that drops to 61% for people with incomes under $35,000.

While 43% of people with incomes under $35,000 say affordability is the reason why they don't go to the eye doctor as often as they'd like, health plan executives say transporation is the key obstacle for members' access to eye care services (88%), highlighting a disconnect. Where health plan executives are concerned about physically getting members to eye doctors' offices, members are more concerned with the costs of care.

"The future of eye care requires us to implement tools that can increase access to care for all patient populations, especially those who are more likely to face systemic barriers. During this pandemic, the rapid advancement of technology has helped us to better meet the needs of vulnerable populations, and we are committed to continuing to explore how it makes healthy sight more accessible," said Klunk.

MethodologyVersant Health's 2nd annual Vision Wellness Study, conducted between October 30 and November 17, 2020, included two distinct surveys fielded by Market Measurement, a custom market research firm. The consumer survey comprises 525 responses from consumers 18 and older. The healthcare plan executive survey comprised 17 responses from health plan executives across the U.S. The survey covered their opinions on routine eye care, access to eye exams, preventative health measures, care costs and other topics related to managed vision care.

About Versant HealthVersant Health, a wholly-owned subsidiary of MetLife, is one of the nation's leading managed vision care companies serving more than 35 million members nationwide. Through our Davis Vision plans and Superior Vision plans, we help members enjoy the wonders of sight through healthy eyes and vision. Providing vision and eye health solutions that range from routine vision benefits to medical management, Versant Health has a unique visibility and scale across the total eye health value chain.As a result, members enjoy a seamless experience with access to one of the broadest provider networks in the industry and an exclusive frame collection.Commercial groups, individuals, third parties, and health plans that serve government-sponsored programs such as Medicaid and Medicare are among our valued customers.

For more information visitversanthealth.com.

SOURCE Versant Health

Home

More here:
Americans Show New Interest In Virtual Eye Care Options, Finds 2nd Annual Vision Wellness Study - PRNewswire

When the vision of his left eye suddenly clouded over, a 57-year-old man was launched into a maze of hospital testing, imaging, and examinations untildays lateran in-depth eye exam revealed the startling and life-threatening cause of his partial blindness, Lisa Sanders writes for the New York Times Magazine.

In September 2020, the patient realized while washing his face that he could no longer see correctlywhile his right eye seemed fine, an "impenetrable gray cloud" hovered over the upper half of everything he could see from his left eye, Sanders writes.

The patient's wife immediately took him to Bridgeport Hospital, where a physician took down all his symptoms: blurry eyesight, a throbbing headache, and pain on the left side of his chest.

Immediately, the doctor ordered an EKG and a blood test in case of heart attack, but the tests came back normal. So did a round of additional testsan CT scan, an MRI, and more blood teststhat the doctor ordered to rule out a potential stroke, tumor, or temporal arteritis, a disease that can destroy arteries in the brain and eye.

The doctor hypothesized the blindness could stem from a migraine, but even after the patient's headache finally cleared up, his partial blindness lingered.

The hospital had ruled out potential causes of blindness stemming from the brain or the area between the brain and eyebut it didn't have the technology to do an in-depth exam of the eye itself. For that procedure, the patient was sent to Jay Wang, a retinal specialist at Yale New Haven Hospital.

After several hours of testing and imaging, Wang identified the problem: While the vessels in the patient's right eye were "perfect," the vessels of the left eye were irregular. Some were brightly spotted in the imaging and others nearly invisibleincluding the artery that supplies blood to the fovea, a section of the retina that is integral to clear vision.

As Wang explained, the imaging indicated that the man had suffered a stroke, with tiny clots of blood travelling through his bloodstream before lodging in his eye, where they had irreparably damaged his vision.

But the man's medical mystery was by no means solved, Wang cautioned: They had to find out where those clots had originated from, or else it could happen again.

Wang sent the patient to Yale New Haven's ED for an echocardiogram. While there, a fourth-year medical student shadowing the case, Joshua Hyman, asked the patient if he could do an initial scan before the official echocardiogram just as a learning exercise. The patient agreed.

But when Hyman placed the ultrasound probe between the patient's third and fourth rib, he didn't see what he should have seen: "the light gray muscles of the two chambers on the left side of the heart squeezing around a dark center of black that is the blood," Sanders writes. Rather, Hyman saw a kiwi-sized "bright ball zooming back and forth across the screen with every heartbeat."

Hyman immediately shared the results with his attending physician, Karen Jubanyik, who confirmed his suspicions: The patient had a myxoma, a rare type of slow-growing tumor, often found in the heart. The tumor had likely been developing for 20 years or so, and the tumor's rough surface provided a haven where blood could pool and eventually form clotsclots that could be launched any time tumor lurched side-to-side.

According to Hyman and Jubanyik, the patient was lucky. Tumors like these, they explained, often presented in cases of stroke or heart attack, but sometimes can grow large enough to block the blood's ability to flow out from the heart, causing sudden death. So far, the patient had only lost some of his vision, they explained, but he needed immediate surgery to excise the tumor before further damage could be done.

Three days later, the patient underwent a successful surgery, and today, he says he feels healthy enough to exercise. While his vision isn't perfect, the patient added, it seems better than it was when the symptoms first hit.

Wang, who had followed his patient's journey, said he was amazed by what the providers in the ED had discovered and grateful the operation went well. "As an ophthalmologist," he said, "I'm used to saving vision. It's not every day you get to save a life" (Sanders, New York Times, 2/4).

View original post here:
His vision suddenly vanished in his left eye. The diagnosis was startlingand life-threatening. - The Daily Briefing

By Chiu Shu-yu and Jonathan Chin / Staff reporter, with staff writer

Intense eye use during long vacations could endanger the eye health of children and adults, a New Taipei City-based ophthalmologist said.

Chu Hsueh-yen (), a doctor at Composite Municipal Hospital in Tucheng (), said that eyestrain from intense use of electronic devices while on vacation could damage vision and lead to myopia in children.

Children with normal eyesight had been observed to have myopia readings of minus-2 diopters following a summer or winter break, Chu said, adding that a myopia reading of minus-5 diopters or higher is linked to increased risks of glaucoma, cataracts and retinal detachment.

Photo courtesy of Taipei Tzu Chi Hospital

Excessive eye use could also lead to dry eyes, a condition increasingly recognized as a disease of civilization. Its symptoms include oversensitivity to light, swelling, blurred vision and tears, he said.

People with dry eyes have suppressed their blink reflex and the normal secretions of the tear duct, he said, adding that untreated dry eyes could lead to corneal injury or vision-affecting corneal ulcers.

When using devices in poorly lit conditions, the pupils dilate and allow more blue light to reach the retina, which could lead to macular degeneration, a serious condition that causes missing spots in the field vision and distortions of shapes, he said.

People should take a rest and put on a warm compress as soon as they feel eye soreness or discomfort, he said, adding that they should see a doctor if the sensations do not go away.

Reading, studying, playing with blocks and using electronic devices are activities that could tax a childs eyes and potentially cause myopia, so parents should make the child rest for five minutes for every 30 minutes of activity, he said.

Children using atropine eye drops a prescription used to control myopia progression should always wear sunglasses when engaging in outdoor activities, or risk greater harm to the eyes from direct sunlight, he said.

Styes are another common post-Lunar New Year affliction which usually stem from a combination of festive comfort foods and lack of sleep, he said.

People can use a warm, clean towel as a compress to treat the condition, but should consult a doctor if the symptom does not improve, he said.

Eating less greasy or sweet food and maintaining good personal hygiene can help prevent such problems, he added.

Comments will be moderated. Keep comments relevant to the article. Remarks containing abusive and obscene language, personal attacks of any kind or promotion will be removed and the user banned. Final decision will be at the discretion of the Taipei Times.

Read more:
Long holidays can be a strain on the eyes, doctor says -

GLEN CARBON Dr. Julie Steinhauer, OD, FCOVD, owner of Vision For Life, and one of a select group of functional vision doctors in the nation, says those with hypertension, known as high blood pressure, may often suffer from undiagnosed vision issues. Left unchecked hypertension can cause blurriness, double vision or a complete loss in one part of the visual field.

Severe hypertension can restrict blood and oxygen to the brain causing an artery to either be blocked or burst. It can induce a stroke, lead to heart and kidney issues, and potentially eye disease.

Those who suffer from hypertension, and their families, should be aware of symptoms of a stroke. According to the National Institute of Health (NIH) website these can include sudden numbness or weakness of the face; weakness in the arm or leg especially on one side of the body; confusion and trouble speaking or understanding speech; issues with walking, dizziness, loss of balance and coordination; and problems seeing in one or both eyes.

Dr. Steinhauer, in her YouTube video How Hypertension Or Stroke Affect Vision, said a stroke will often damage a visual pathway causing a loss in the vision field. Eyesight becomes altered. Some may have significant loss of vision, blurriness or a blind spot. In many cases the individual doesnt even realize they have suffered a vision loss after the stroke has occurred.

According to Steinhauer, family members should be aware of these symptoms if they see a loved one acting differently, especially following a stroke diagnosis. They may have blurred vision while watching TV, or what we call visual neglect where the individual ignores stimuli on either the left or right side. Other symptoms include problems when reading, and bumping into objects while walking.

A thorough diagnosis can reveal any eye damage that has occurred as a result of a stroke and best course of treatment. In many cases the eye-brain connection can be retrained using a light therapy called Syntonics. This helps ignite the neurons in the brain that were turned off as a result of the stroke. The patient can gain back some of the normal visual field. An eye doctor can properly evaluate and diagnose vision loss, no matter the age of the patient.

Dr. Steinhauer said functional vision therapy helps to regain 30% to 80% of a stroke patients vision loss. Timing is important because the quicker therapy begins post stroke the better the chances for more visual recovery.

The goal is to let people know that they can regain their vision due to severe hypertension or after a stroke. Utilizing proper therapy we can help improve their ability to read, write, and work, and enjoy life to its fullest.

For additional information visit https://visionforlifeworks.com.

Like RiverBender.com on Facebook!

Print Version Submit a News Tip

See the original post here:
Dr. Julie Steinhauer in Glen Carbon Reveals Treatment Procedure For Vision Compromised By Hypertension and Stroke - RiverBender.com